These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [The value of psychopharmacotherapy in the treatment of borderline personality disorder]. Leitner P; Serfling R Psychiatr Prax; 1993 Nov; 20(6):207-10. PubMed ID: 7906044 [TBL] [Abstract][Full Text] [Related]
13. Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. American Psychiatric Association Practice Guidelines Am J Psychiatry; 2001 Oct; 158(10 Suppl):1-52. PubMed ID: 11665545 [No Abstract] [Full Text] [Related]
14. [Drug therapy of patients with emotionally unstable personality]. Nissen T Tidsskr Nor Laegeforen; 2000 Aug; 120(18):2135-41. PubMed ID: 11006733 [TBL] [Abstract][Full Text] [Related]
15. Psychopharmacologic management of patients with borderline personality disorder. Links PS; Steiner M Can J Psychiatry; 1988 Jun; 33(5):355-9. PubMed ID: 3044565 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacological treatment of borderline personality disorders. Several options for symptom reduction but nothing for the disorder per se]. Rydén G; Vinnars B Lakartidningen; 2002 Dec; 99(50):5088-94. PubMed ID: 12572301 [TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of the borderline patient: a critical review and clinical guidelines. Kutcher SP; Blackwood DH Can J Psychiatry; 1989 May; 34(4):347-53. PubMed ID: 2567621 [TBL] [Abstract][Full Text] [Related]
20. Development of melancholia during carbamazepine treatment in borderline personality disorder. Gardner DL; Cowdry RW J Clin Psychopharmacol; 1986 Aug; 6(4):236-9. PubMed ID: 3525615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]